12/19/2022 7:08:07 AM
Vanda Pharma : Fanapt Shown To Be Effective In Bipolar I Disorder In Phase III Clinical Study
12/2/2022 7:01:22 AM
Vanda Pharma Reports Results In Phase II Clinical Study Of VQW-765 In The Treatment Of Acute Performance Anxiety
1/14/2022 8:38:37 AM
Vanda Pharma Settles HETLIOZ Patent Litigation With MSN
8/3/2021 7:21:22 AM
Vanda Closes Enrollment In ODYSSEY Study Comparing Tradipitant And Placebo In Hospitalized COVID-19 Pneumonia Patients
4/6/2018 8:53:19 AM
Jefferies Is Cutting VANDA PHARMACEUTICALS (VNDA) 2020 Estimate To 0.61 From 0.67
4/6/2018 8:53:03 AM
Jefferies Is Lowering VANDA PHARMACEUTICALS (VNDA) 2019 Estimate To 0.83 From 0.92
4/6/2018 8:52:40 AM
Jefferies Is Raising VANDA PHARMACEUTICALS (VNDA) 2018 Estimate To -0.83 From -0.92
4/6/2017 6:15:05 AM
Jefferies Is Cutting VANDA PHARMACEUTICALS (VNDA) 2018 Estimate To -0.39 From -0.17
1/5/2017 6:24:33 AM
Jefferies Is Increasing VANDA PHARMACEUTICALS (VNDA) 2017 Estimate To 0.03 From -0.04
1/5/2017 6:24:17 AM
Jefferies Is Cutting VANDA PHARMACEUTICALS (VNDA) 2016 Estimate To -0.48 From -0.43